Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2012

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

Doxorubicin

measurements of serum Doxorubicin levels

Trial Locations (1)

44281

Departmetn of Medicine. Meir Medical Center, Kfar Saba

Sponsors
All Listed Sponsors
lead

Meir Medical Center

OTHER